Gynecologic Oncology Reports · 2019 · 15 citations · 15 references
MedicineGynecologyOncologyGynecologic OncologyOncologic ImagingSarcopeniaCancer BiomarkersEndometrial CancerMuscle Mass AssessmentSarcopenic ObesityAbdominal Visceral FatEndometrial Cancer ChemotherapyEndometrial Carcinoma ImagingLow Body Mass IndexObesity-related SarcopeniaPsoas Muscle AreaSubcutaneous Fat LossVisceral Fat Accumulation
OBJECTIVE: To examine associations of body mass index (BMI), subcutaneous fat area (SFA) and density (SFD), visceral fat area (VFA) and density (VFD) and total psoas area (TPA) to outcomes among patients receiving chemotherapy with or without bevacizumab for advanced or recurrent endometrial cancer (EC). METHODS: This was a multi-institutional, retrospective study of patients with EC treated with and without bevacizumab as part of front-line, platinum based chemotherapy. Demographics and clinical characteristics were collected. SFA, VFA, SFD, VFD, and TPA were determined from pre-treatment CT scans using a deep learning algorithm. Data was compared with overall survival (OS) and progression free survival (PFS). RESULTS: . PFS and OS did not differ between patients with BMI, SFA, VFA, SFD, VFD, or TPA ≥ the 50th percentile compared to <50th percentile (p = 0.91, 0.45, 0.71, 0.74, 0.60, and 0.74 respectively) and (p = 0.99, 0.59, 0.14, 0.77, and 0.85 respectively). When adjusting for prognostic factors, elevated VFA trended towards shorter OS (25.1 vs 59.5 months, HR = 1.68 [0.92-3.05]).Patients receiving bevacizumab had similar OS compared to those who did not (37.6 vs 44.5 months, p = 0.409). When stratified by adiposity markers, no subset demonstrated benefit from bevacizumab. CONCLUSION: Obesity has been associated with increased levels of vascular endothelial growth factor (VEGF), the main target for bevacizumab therapy. Imaging measurements of VFA may provide prognostic information for patients with EC but no adiposity marker was predictive of improved response to bevacizumab.
15
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
Caroline S. Fox, Joseph M. Massaro, Udo Hoffmann et al. · Circulation · 2007 · 2.9K citations · Full text
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Melina Arnold, Nirmala Pandeya, Graham Byrnes et al. · The Lancet Oncology · 2014 · 993 citations · Full text
Medicine, Health Policy, Oncology +17